IL31 and Alzheimer disease: These pathways include cytokines, such as IL-4, IL-13, IL-31, and TSLP, and chemokines, such as CCL1, CCL13, and CCL17, which have been implicated in barrier disruption, pruritus, and immune cell recruitment in AD (82, 83).